Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

Nearly 30% of the data collected in clinical trials do not directly inform key decisions, yet patients are still asked to ...

China Food and Drug Administration (CFDA) is facing increasing pressure as a backlog of pharmaceutical marketing and clinical trial applications grow, though trial standards there are approaching ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Medication adherence in clinical trials is notoriously hard to track with precision.

Researchers determined that between 25% and 30% of the burden placed on trial participants was due to the collection of data that didn't ultimately support the trial's key endpoints. (iStock / Getty ...

A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by their treatment. The FDA wants to change that, and it has started running ...

Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide ...

IQVIA controls one of the world's largest databases of healthcare information that's closely integrated the clinical research ...

In 2020, a microscopic airborne pathogen stopped the world. The COVID-19 pandemic led to school closures, lockdown orders, mask mandates, and newfound hobbies for thousands of Americans. While many ...

Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...